Pfizer
Ashley Modell is a Senior Scientist at Pfizer since April 2022, bringing a robust background in chemistry and scientific research. Prior roles include two postdoctoral associate positions at Harvard Medical School and the Broad Institute of MIT and Harvard from February 2020 to February 2022, where key contributions included developing strategic partnerships and serving as Project Manager for a DARPA grant. Ashley's doctoral research at New York University focused on fragment-based approaches to targeting protein interactions, culminating in 7+ publications, 12 grants, and 1 patent. Earlier experience includes a research assistantship at Memorial Sloan-Kettering Cancer Center, investigating RUNX1 post-translational modifications in leukemia cell lines. Ashley holds a Ph.D. in Chemistry from New York University and a B.A. in Chemistry from Boston University.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.